Pages that link to "Q30417445"
Jump to navigation
Jump to search
The following pages link to Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling (Q30417445):
Displaying 7 items.
- Systemic injection of AAV9 carrying a periostin promoter targets gene expression to a myofibroblast-like lineage in mouse hearts after reperfused myocardial infarction (Q30277247) (← links)
- A novel cardiac muscle-derived biomaterial reduces dyskinesia and postinfarct left ventricular remodeling in a mouse model of myocardial infarction (Q30300274) (← links)
- Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling (Q30301118) (← links)
- Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver (Q30417032) (← links)
- A step closer to cardiac optogenetics in vivo (Q51040280) (← links)
- Non-viral vector based gene transfection with human induced pluripotent stem cells derived cardiomyocytes (Q90575279) (← links)
- Implications of scar structure and mechanics for post-infarction cardiac repair and regeneration (Q90899128) (← links)